Status:
COMPLETED
Qigong to Improve Frailty Among Older Cancer Survivors
Lead Sponsor:
The University of Hong Kong
Conditions:
Cancer
Frailty
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The objective of the study is to examine the effects of a 16-week Baduanjin qigong intervention on frailty, physical performance, psychological well-being, and health-related quality of life (HRQoL) a...
Detailed Description
The number of cancer survivors is rising worldwide. For example, in the United States, the number of cancer survivors is projected to increase by 31%, from 16.9 million in 2019 to 22.2 million by 2030...
Eligibility Criteria
Inclusion
- aged ≥65
- diagnosed with stage I-III non-metastatic cancer
- completed primary treatment with curative intent (surgery, chemotherapy, and/or radiation therapy) 6 months to 5 years prior to baseline assessments with no recurrence or occurrence of additional cancers
- classified as pre-frail or frail based on Fried frailty criteria
- can communicate in Cantonese or Putonghua
- written informed consent
Exclusion
- regular qigong training or other mind body intervention (once or more per week) within the previous 6 months
- medical conditions affecting mobility, predisposing to falls, or precluding qigong practice (e.g., neurological disease, musculoskeletal disorder, recent myocardial infarction, breathing difficulties requiring oxygen)
Key Trial Info
Start Date :
February 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT04692233
Start Date
February 19 2021
End Date
July 31 2024
Last Update
May 28 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong, 000
2
Pamela Youde Nethersole Eastern Hospital
Hong Kong, Hong Kong